Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?

Journal article

Open access

Peer reviewed

B. Nobile, M. Durand, P. Courtet, P. van de Perre, N. Nagot, J.P. Molès and E. Olié

Schizophrenia Research

07/2020

PMCID: PMC7381925

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1016/j.schres.2020.07.015View

Published (Version of record) Open

1 Record Views

Title: Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
Creators - without role: B. Nobile - Centre Hospitalier Universitaire de Montpellier
M. Durand - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
P. Courtet - Fondation FondaMental
P. van de Perre - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
N. Nagot - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
J.P. Molès - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
E. Olié - Université de Montpellier
Publication Details: Schizophrenia Research
Identifiers: 9938361009311
Academic Unit: Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
Language: English
Resource Type: Journal article
Local Fields: hal-02907269